Top 3 OTC-BB and Pink Sheet Market Movers
Aethlon Medical, Inc. (AEMD), Golden Phoenix Minerals, Inc. (GPXM), and Pulmo BioTech Inc. (PLMO) were among today’s top OTC market movers.
Aethlon Medical, Inc. [[AEMD.OB]], which creates diagnostic and therapeutic device solutions for infectious disease and cancer, saw its shares rise by more than 30 percent after announcing that it established Exosome Sciences, Inc. as a subsidiary to leverage its recent discovery that the Hemopurifier® is effective in capturing exosomes that are secreted by solid tumors, lymphomas, and leukemia to suppress the immune response in cancer patients.
Golden Phoenix Minerals, Inc. [[GPXM.OB]], which explores and develops mineral properties, saw its shares rise more than 20 percent after issuing a letter to shareholders. The letter notes that gold continues to remain strong amid economic uncertainty, while there is strong interest in its Mineral Ridge gold mine that is permitted and bonded. “Now more than ever the ‘Phoenix’ has re-risen from the ashes, and is poised on what I believe is the start of the next major move in metals,” said President Robert Martin in the letter.
Pulmo BioTech Inc. [[PLMO.OB]], which is a development stage medical company, saw its shares drop more than 30 percent following some profit-taking after its bullish announcement on Wednesday. The company announced that it signed a letter of intent with BioTechnology Consulting Poland to license its Pulmonary Vascular Diagnostic Product Candidate PulmoBlind to develop work, clinical trials and ultimately commercialization in the European Market.
CONTACT: Daniel Minton, Managing Director, 406-862-5400, daniel@accelerize.com